{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:38:38Z","timestamp":1793709518606,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacl.2026.07.032","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:12:44Z","timestamp":1785539564000},"page":"1827-1839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Birth and first-year outcomes in infants of mothers with familial hypercholesterolemia or atherosclerotic cardiovascular disease in the US: A retrospective cohort study"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-1674","authenticated-orcid":false,"given":"Xinyue","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6506-0243","authenticated-orcid":false,"given":"Michelle","family":"Fanous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Ponda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5568-2510","authenticated-orcid":false,"given":"Alexander","family":"Breskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0532-093X","authenticated-orcid":false,"given":"Isha M.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-2111","authenticated-orcid":false,"given":"Caitlin","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jacl.2026.07.032_bib1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","article-title":"Prevalence of familial hypercholesterolemia in the 1999\u20132012 United States National Health and Nutrition Examination Surveys (NHANES)","volume":"133","author":"de Ferranti","year":"2016","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.jacl.2026.07.032_bib2","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacl.2026.07.032_bib3","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.jacl.2011.03.451","article-title":"Treatment of adults with familial hypercholesterolemia and evidence for treatment: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Robinson","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"45","key":"10.1016\/j.jacl.2026.07.032_bib4","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.07.032_bib5","article-title":"The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: lower for longer is better","volume":"18","author":"Mhaimeed","year":"2024","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2026.07.032_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","article-title":"Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype","volume":"134","author":"Perak","year":"2016","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jacl.2026.07.032_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11883-022-01037-3","article-title":"LDL-C: the only causal risk factor for ASCVD. Why is it still overlooked and underestimated?","volume":"24","author":"Ferhatbegovi\u0107","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2026.07.032_bib8","article-title":"Trends in prevalence, risk factor control and medications in atherosclerotic cardiovascular disease among US adults, 1999\u20132018","volume":"17","author":"Zhang","year":"2024","journal-title":"Am J Prev Cardiol"},{"issue":"13","key":"10.1016\/j.jacl.2026.07.032_bib9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jacc.2020.07.059","article-title":"Time course of LDL cholesterol exposure and cardiovascular disease event risk","volume":"76","author":"Domanski","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacl.2026.07.032_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCOUTCOMES.122.009787","article-title":"Gaps in guideline-based lipid-lowering therapy for secondary prevention in the United States: a retrospective cohort study of 322 153 patients","volume":"16","author":"Navar","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"11","key":"10.1016\/j.jacl.2026.07.032_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25505","article-title":"Assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016","volume":"3","author":"Yao","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.jacl.2026.07.032_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae032","article-title":"Dyslipidaemia management in pregnant patients: a 2024 update","volume":"4","author":"Lewek","year":"2024","journal-title":"Eur Heart J Open"},{"issue":"6","key":"10.1016\/j.jacl.2026.07.032_bib13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2217\/clp.10.64","article-title":"Maternal lipid metabolism during normal pregnancy and its implications to fetal development","volume":"5","author":"Herrera","year":"2010","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.07.032_bib14","series-title":"Endotext [Internet]","article-title":"Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels","author":"Wild","year":"2000"},{"issue":"4","key":"10.1016\/j.jacl.2026.07.032_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/aje\/kwu145","article-title":"Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis","volume":"180","author":"Spracklen","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.jacl.2026.07.032_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/1471-0528.13261","article-title":"Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis","volume":"122","author":"Ryckman","year":"2015","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.jacl.2026.07.032_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00404-016-4216-5","article-title":"Maternal lipid profile and the relation with spontaneous preterm delivery: a systematic review","volume":"295","author":"Moayeri","year":"2017","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.jacl.2026.07.032_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the national lipid association expert panel on familial hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"25","key":"10.1016\/j.jacl.2026.07.032_bib19","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacl.2026.07.032_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jacc.2016.03.519","volume":"68","author":"Lloyd-Jones","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.07.032_bib21","article-title":"Application of administrative claims-based algorithms to characterize pregnancy in atherosclerotic cardiovascular disease or likely familial hypercholesterolemia","author":"Isha Mehta","year":"2025","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"15","key":"10.1016\/j.jacl.2026.07.032_bib22","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.110.990929","article-title":"Pregnancy outcomes in familial hypercholesterolemia: a registry-based study","volume":"124","author":"Toleikyte","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.07.032_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120442","article-title":"Risk of adverse pregnancy outcomes and impact of statin use in pregnant women with familial hypercholesterolemia","volume":"408","author":"Svendsen","year":"2025","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.jacl.2026.07.032_bib24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/pds.5483","article-title":"Identification of pregnancies and infants within a US commercial healthcare administrative claims database","volume":"31","author":"Bertoia","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.jacl.2026.07.032_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40264-022-01261-5","article-title":"Development and validation of ICD-10-CM-based algorithms for date of last menstrual period, pregnancy outcomes, and infant outcomes","volume":"46","author":"Chomistek","year":"2023","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.jacl.2026.07.032_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacl.2021.09.045","article-title":"Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH)\u2013results of a US national survey","volume":"15","author":"Block","year":"2021","journal-title":"J Clin Lipidol"},{"issue":"24","key":"10.1016\/j.jacl.2026.07.032_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and treatment of heterozygous familial hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2026.07.032_bib28","first-page":"1020","article-title":"Using healthcare claims data to identify health disparities for individuals with familial hypercholesterolemia","volume":"19","author":"McGowan","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"10","key":"10.1016\/j.jacl.2026.07.032_bib29","first-page":"1457","article-title":"Patient characteristics and acute cardiovascular event rates among patients with very high-risk and non-very high-risk atherosclerotic cardiovascular disease","volume":"44","author":"Fonarow","year":"2021","journal-title":"Clin\u00a0Cardiol"},{"issue":"11","key":"10.1016\/j.jacl.2026.07.032_bib30","article-title":"Familial hypercholesterolemia: a literature review of the pathophysiology and current and novel treatments","volume":"15","author":"Suryawanshi","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.jacl.2026.07.032_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3233\/NPM-230014","article-title":"Identifying neonatal intensive care (NICU) admissions using administrative claims data","volume":"16","author":"Vance","year":"2023","journal-title":"J Neonatal-Perinatal Med"},{"key":"10.1016\/j.jacl.2026.07.032_bib32","unstructured":"New York State Department of Health Birth Defects Registry. List of all reportable congenital malformations. Accessed 6 January, 2026. https:\/\/www.health.state.ny.us\/diseases\/birth_defects\/docs\/icd10.pdf."},{"issue":"1","key":"10.1016\/j.jacl.2026.07.032_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/bdr2.2301","article-title":"National population-based estimates for major birth defects, 2016\u20132020","volume":"116","author":"Stallings","year":"2024","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.jacl.2026.07.032_bib34","unstructured":"FDA Center for Drug Evaluation and Research. Improving the identification of pregnancies in claims data: A descriptive analysis. Updated 26 August 2025. Accessed January 6, 2026. https:\/\/www.sentinelinitiative.org\/studies\/drugs\/individual-drug-analyses\/improving-identification-pregnancies-claims-data-descriptive."},{"issue":"118645","key":"10.1016\/j.jacl.2026.07.032_bib35","first-page":"17","article-title":"Risk of pregnancy- and birth-related outcomes in women with familial hypercholesterolemia versus age-matched controls","volume":"395","author":"Svendsen","year":"2024","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.jacl.2026.07.032_bib36","doi-asserted-by":"crossref","first-page":"23905","DOI":"10.3390\/ijms161023905","article-title":"Cardiovascular complications of pregnancy","volume":"16","author":"Gongora","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"32","key":"10.1016\/j.jacl.2026.07.032_bib37","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.07.032_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100830","article-title":"Association of maternal lipid profile and gestational diabetes mellitus: a systematic review and meta-analysis of 292 studies and 97,880 women","volume":"34","author":"Hu","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.jacl.2026.07.032_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jama.2021.11922","article-title":"Screening for gestational diabetes: US preventive services task force recommendation statement","volume":"326","author":"Force","year":"2021","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.jacl.2026.07.032_bib40","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/02813432.2024.2378204","article-title":"To neutrally offer or strongly recommend? General practitioners\u2019 perspectives on screening for gestational diabetes according to the national guideline in Norway","volume":"42","author":"Forthun","year":"2024","journal-title":"Scand J Prim Health Care"},{"issue":"9","key":"10.1016\/j.jacl.2026.07.032_bib41","first-page":"936","article-title":"Estimation of missed statin prescription use in an administrative claims dataset","volume":"23","author":"Wade","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"10.1016\/j.jacl.2026.07.032_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamacardio.2016.5162","article-title":"Rate of statin prescription in younger patients with severe dyslipidemia","volume":"2","author":"Al-Kindi","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2026.07.032_bib43","first-page":"10063","article-title":"Follow-up lipid testing and statin initiation among young adults in a US healthcare system","volume":"S0735-1097","author":"Harrison","year":"2025","journal-title":"JACC"},{"issue":"4","key":"10.1016\/j.jacl.2026.07.032_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/bdra.23001","article-title":"Using ICD-9 codes to establish prevalence of malformations in newborn infants","volume":"94","author":"Holmes","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:18:25Z","timestamp":1793708305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426004630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1933287426004630"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.032","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Birth and first-year outcomes in infants of mothers with familial hypercholesterolemia or atherosclerotic cardiovascular disease in the US: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}